Alan G. Harris MD, PhD: Chair of the Inaugural Gordon Research Conference (GRC) on Radionuclide Theranostics for the Management of Cancer July 17-22, 2022.
Joined March 2022
- Tweets32
- Following320
- Followers208
- Likes0
Thanks to all the Speakers, Attendees and Sponsors for making the Inaugural GRC on Radionuclide Theranostics in Cancer such a great success!
Looking forward to seeing you all at the next GRC Theranostics get-together in 2024!
Don't miss the Inaugural Radiotheranostics GRC. Travel stipends are available. The GRC Carl Storm Underrepresented Minority Fellowship Program provides financial assistance to qualified applicants. See the Meeting website for details: grc.org/radionuclide-therano…
#theranostics
Fellows, residents, trainees interested in #Theranostics in #cancer, don't miss the deadline for Oral Presentations (June 10th) at our Inaugural Gordon Research Conference. Still some opportunities for Travel and Registration Grant Assistance!! Go to grc.org/radionuclide-therano…
We are really looking forward to hearing from Dr. Corinne Beinat speak on "From Brain PET Imaging to Peptide Receptor Radionuclide Therapy" at the Radionuclide Theranostics for the Management of Cancer GRC this July.
1
6
Her group additionally develops novel peptide based theragnostic agents for stratification of patients with high receptor expression, treatment with targeted radionuclide therapy, and subsequent monitoring of treatment response.
1
The Radionuclide Theranostics for the Management of Cancer GRC takes place July 17-22, 2002 at the Jordan Hotel at Sunday River, Newry, Maine. Information about the Program and Attendance can be found at grc.org/radionuclide-therano…
1
Dr. Andrew M Bellizzi, M.D. will be bringing his insights on clinical pathology to the 2022 Radionuclide Theranostics for the Management of Cancer GRC, where he will speak about "Immunohistochemistry to Confirm Protein Targets in Cancer Cells".
1
2
Dr. Bellizzi is a Clinical Professor in the Department of Pathology at the University of Iowa. His research interests include the diagnosis, classification, and etiopathogenesis of diseases like gastrointestinal, pancreatic, neuroendocrine & hereditary tumors.
1
The Radionuclide Theranostics for the Management of Cancer GRC takes place July 17-22, 2002 at the Jordan Hotel at Sunday River, Newry, Maine. Information about the Program and Attendance can be found at grc.org/radionuclide-therano…
@GordonConf @GRCTheranostics
The Radionuclide Theranostics for the Management of Cancer GRC is delighted to welcome Dr. Richard L. Wahl, a world-renowned leader in molecular imaging and therapy and current President of the SNMMI. He will speak on “Radiolabeled Monoclonal Antibodies for Radiotheranostics”.
The Radionuclide Theranostics for the Management of Cancer GRC takes place July 17-22, 2002 at the Jordan Hotel at Sunday River, Newry, Maine. The deadline for applications to attend this GRC is June 19, 2022.
1
Information about the Program and Attendance can be found at grc.org/radionuclide-therano…
Dr E. Delpassand will lecture on "Targeted Alpha Particle Therapy (212Pb-DOTAMTATE ) in PRRT Naïve and Progressive NETS Patients at our @GordonConf on Radiotheranostics in Cancer and present a poster @ASCO 2022 meetings.asco.org/abstracts-…
See our Final Gordon Research Conference Program and Apply to Attend at grc.org/radionuclide-therano…
#theranostics #Cancer #GRCTheranostics
The Radionuclide Theranostics in Cancer GRC will take place July 17-22, 2022 at the Jordan Hotel at Sunday River, Newry, Maine. Places are limited, so for further information and to view the Final program go to grc.org/radionuclide-therano…
1
Delighted to announce that the 2022 Gordon Research Conference (GRC) @GordonConf on “Radionuclide Theranostics for the Management of Cancer: Molecularly Targeted, Radioactive Cancer Diagnosis and Therapy” has been awarded an R13 Grant from the National Cancer Institute. @theNCI
This new GRC has a unique venue and is a pivotal opportunity to unify basic and translational researchers in radionuclide theranostics and cancer with the goal of promoting cutting-edge discoveries and their translation into diagnostics and treatments for cancer.
1
Follow @GRCTheranostics for regular updates on the Program, Speakers, Topics and other essential information.
@GordonConf @GRCTheranostics @alangharris